Summary
The U.S. government is looking for the next AZT, Viagra and thalidomide — substances that washed out as treatments for one disease but later turned out to work well against a totally different ailment.
Description
For academic scientists, the advantage of the collaboration is that they get access to compounds with information that has taken years and millions of dollars to generate. That includes a molecule’s pharmacological effects — what receptors and enzymes it blocks or stimulates — as well as safe doses and side effects.